메뉴 건너뛰기




Volumn 6, Issue 4, 2010, Pages 422-431

Cyclosporin a loaded PLGA nanoparticle: Preparation, optimization, In-Vitro characterization and stability studies

Author keywords

AFM; Cyclosporin a; Freeze drying; Nanoparticles; PLGA; XRD

Indexed keywords

AFM; CYCLOSPORIN A; FREEZE DRYING; PLGA; XRD;

EID: 78449242762     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341310791658937     Document Type: Article
Times cited : (56)

References (35)
  • 2
    • 84884044858 scopus 로고    scopus 로고
    • xPharm: The Comprehensive Pharmacology Reference; Elsevier: New York
    • Scholar, E.; Enna, S.J.; David, B.B. Cyclosporin. In xPharm: The Comprehensive Pharmacology Reference; Elsevier: New York, 2007, pp. 1-8.
    • (2007) Cyclosporin , pp. 1-8
    • Scholar, E.1    Enna, S.J.2    David, B.B.3
  • 3
    • 0028820208 scopus 로고
    • Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine
    • Wu, C.Y.; Benet, L.Z.; Hebert, M.F.; Gupta, S.K.; Rowland, M.; Gomez, D.Y.; Wacher, V.J. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin. Pharmacol. Ther., 1995, 58(5), 492-497.
    • (1995) Clin. Pharmacol. Ther , vol.58 , Issue.5 , pp. 492-497
    • Wu, C.Y.1    Benet, L.Z.2    Hebert, M.F.3    Gupta, S.K.4    Rowland, M.5    Gomez, D.Y.6    Wacher, V.J.7
  • 4
    • 0033134854 scopus 로고    scopus 로고
    • Considerations concerning generic formulations of immunosuppressive drugs
    • Kahan, B.D. Considerations concerning generic formulations of immunosuppressive drugs. Transpl. Proc., 1999, 31(3), 1635-1641.
    • (1999) Transpl. Proc , vol.31 , Issue.3 , pp. 1635-1641
    • Kahan, B.D.1
  • 5
    • 0030803356 scopus 로고    scopus 로고
    • Switching between cyclosporine formulations. What are the risks?
    • Olyaei, A.J.; deMattos, A.M.; Bennett, W.M. Switching between cyclosporine formulations. What are the risks? Drug Saf., 1997, 16(6), 366-373.
    • (1997) Drug Saf , vol.16 , Issue.6 , pp. 366-373
    • Olyaei, A.J.1    Demattos, A.M.2    Bennett, W.M.3
  • 6
    • 0029017526 scopus 로고
    • Percutaneous absorption and dermal delivery of cyclosporin
    • Choi, H.K.; Flynn, G.L.; Amidon, G.L. Percutaneous absorption and dermal delivery of cyclosporin A. J. Pharm. Sci., 1995, 84(5), 581-583.
    • (1995) A. J. Pharm. Sci , vol.84 , Issue.5 , pp. 581-583
    • Choi, H.K.1    Flynn, G.L.2    Amidon, G.L.3
  • 7
    • 15544362279 scopus 로고    scopus 로고
    • Polymeric particulates to improve oral bioavailability of peptide drugs
    • Delie, F.; Blanco-Prieto, M.J. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules, 2005, 10(1), 65-80.
    • (2005) Molecules , vol.10 , Issue.1 , pp. 65-80
    • Delie, F.1    Blanco-Prieto, M.J.2
  • 8
  • 9
    • 0027383302 scopus 로고
    • Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A
    • Sánchez, A.; Vila-Jato, J.; Alonso, M.J. Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A. Int. J. Pharm., 1993, 99(2-3), 263-273.
    • (1993) Int. J. Pharm , vol.99 , Issue.2-3 , pp. 263-273
    • Sánchez, A.1    Vila-Jato, J.2    Alonso, M.J.3
  • 10
    • 0030572633 scopus 로고    scopus 로고
    • Optimized preparation of poly (lactic-glycolic) microspheres and nanoparticles for oral administration
    • Chacón, M.; Berges, L.; Molpeceres, J.; Aberturas, M.R.; Guzman, M. Optimized preparation of poly (lactic-glycolic) microspheres and nanoparticles for oral administration. Int. J. Pharm., 1996, 141(1-2), 81-91.
    • (1996) Int. J. Pharm , vol.141 , Issue.1-2 , pp. 81-91
    • Chacón, M.1    Berges, L.2    Molpeceres, J.3    Aberturas, M.R.4    Guzman, M.5
  • 11
    • 0032850436 scopus 로고    scopus 로고
    • Polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy
    • Molpeceres, J.; Chacón, M.; Guzmán, M.; Berges, L.; del Rosario Aberturas, M. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy. Int. J. Pharm., 1999, 187(1), 101-113.
    • (1999) Int. J. Pharm , vol.187 , Issue.1 , pp. 101-113
    • Molpeceres, J.1    Chacón, M.2    Guzmán, M.3    Berges, L.4    Del, R.5    Aberturas, M.A.6
  • 12
    • 0037028069 scopus 로고    scopus 로고
    • Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer
    • Lee, W.-K.; Park, J.-Y.; Yang, E.H.; Suh, H.; Kim, S.H.; Chung, D.S.; Choi, K.; Yang, C.W.; Park, J.-S. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. J. Control. Release, 2002, 84(3), 115-123.
    • (2002) J. Control. Release , vol.84 , Issue.3 , pp. 115-123
    • Lee, W.-K.1    Park, J.-Y.2    Yang, E.H.3    Suh, H.4    Kim, S.H.5    Chung, D.S.6    Choi, K.7    Yang, C.W.8    Park, J.-S.9
  • 13
    • 1842525943 scopus 로고    scopus 로고
    • Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process
    • Jaiswal, J.; Kumar Gupta, S.; Kreuter, J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J. Control. Release, 2004, 96(1), 169-178.
    • (2004) J. Control. Release , vol.96 , Issue.1 , pp. 169-178
    • Jaiswal, J.1    Kumar, G.S.2    Kreuter, J.3
  • 14
    • 0037027833 scopus 로고    scopus 로고
    • Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
    • El-Shabouri, M.H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm., 2002, 249(1-2), 101-108.
    • (2002) Int. J. Pharm , vol.249 , Issue.1-2 , pp. 101-108
    • El-Shabouri, M.H.1
  • 15
    • 32244438967 scopus 로고    scopus 로고
    • Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy
    • Hariharan, S.; Bhardwaj, V.; Bala, I.; Sitterberg, J.; Bakowsky, U.; Ravi Kumar, M.N. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm. Res., 2006, 23(1), 184-195.
    • (2006) Pharm. Res , vol.23 , Issue.1 , pp. 184-195
    • Hariharan, S.1    Bhardwaj, V.2    Bala, I.3    Sitterberg, J.4    Bakowsky, U.5    Ravi, K.M.N.6
  • 16
    • 34249087392 scopus 로고    scopus 로고
    • PLGA nanoparticles for oral delivery of cyclosporine: Ne.phrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®
    • Italia, J.L.; Bhatt, D.K.; Bhardwaj, V.; Tikoo, K.; Kumar, M.N.V.R. PLGA nanoparticles for oral delivery of cyclosporine: Ne.phrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral ®. J. Control. Release, 2007, 119(2), 197-206.
    • (2007) J. Control. Release , vol.119 , Issue.2 , pp. 197-206
    • Italia, J.L.1    Bhatt, D.K.2    Bhardwaj, V.3    Tikoo, K.4    Kumar, M.N.V.R.5
  • 17
    • 0033790335 scopus 로고    scopus 로고
    • Freeze-drying of polycaprolactone and poly(-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs
    • Saez, A.; Guzmán, M.; Molpeceres, J.; Aberturas, M.R. Freeze-drying of polycaprolactone and poly(-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur. J. Pharm. Biopharm., 2000, 50(3), 379-387.
    • (2000) Eur. J. Pharm. Biopharm , vol.50 , Issue.3 , pp. 379-387
    • Saez, A.1    Guzmán, M.2    Molpeceres, J.3    Aberturas, M.R.4
  • 18
    • 33646830139 scopus 로고    scopus 로고
    • Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage
    • Abdelwahed, W.; Degobert, G.; Fessi, H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur. J. Pharm. Biopharm., 2006, 63(2), 87-94.
    • (2006) Eur. J. Pharm. Biopharm , vol.63 , Issue.2 , pp. 87-94
    • Abdelwahed, W.1    Degobert, G.2    Fessi, H.3
  • 19
    • 67349119561 scopus 로고    scopus 로고
    • Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage
    • Holzer, M.; Vogel, V.; Mantele, W.; Schwartz, D.; Haase, W.; Langer, K. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage. Eur. J. Pharm. Biopharm., 2009, 72(2), 428-437.
    • (2009) Eur. J. Pharm. Biopharm , vol.72 , Issue.2 , pp. 428-437
    • Holzer, M.1    Vogel, V.2    Mantele, W.3    Schwartz, D.4    Haase, W.5    Langer, K.6
  • 20
    • 60049090585 scopus 로고    scopus 로고
    • Design of biodegradable nanoparticles for oral delivery of doxorubicin: In-vivo pharmacokinetics and toxicity studies in rats
    • Kalaria, D.R.; Sharma, G.; Beniwal, V.; Ravi Kumar, M.N. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in-vivo pharmacokinetics and toxicity studies in rats. Pharm. Res., 2009, 26(3), 492-501.
    • (2009) Pharm. Res , vol.26 , Issue.3 , pp. 492-501
    • Kalaria, D.R.1    Sharma, G.2    Beniwal, V.3    Ravi, K.M.N.4
  • 21
    • 67349107075 scopus 로고    scopus 로고
    • Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
    • Shaikh, J.; Ankola, D.D.; Beniwal, V.; Singh, D.; Kumar, M.N. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci., 2009, 37(3-4), 223-230.
    • (2009) Eur. J. Pharm. Sci , vol.37 , Issue.3-4 , pp. 223-230
    • Shaikh, J.1    Ankola, D.D.2    Beniwal, V.3    Singh, D.4    Kumar, M.N.5
  • 22
    • 43249085707 scopus 로고    scopus 로고
    • The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM)
    • Zhang, L.; Liu, L.; Qian, Y.; Chen, Y. The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). Eur. J. Pharm. Biopharm., 2008, 69(2), 750-759.
    • (2008) Eur. J. Pharm. Biopharm , vol.69 , Issue.2 , pp. 750-759
    • Zhang, L.1    Liu, L.2    Qian, Y.3    Chen, Y.4
  • 23
    • 0037093720 scopus 로고    scopus 로고
    • Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study
    • Vandervoort, J.; Ludwig, A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int. J. Pharm., 2002, 238(1-2), 77-92.
    • (2002) Int. J. Pharm , vol.238 , Issue.1-2 , pp. 77-92
    • Vandervoort, J.1    Ludwig, A.2
  • 24
    • 0032964174 scopus 로고    scopus 로고
    • Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS
    • Scholes, P.D.; Coombes, A.G.A.; Illum, L.; Davis, S.S.; Watts, J.F.; Ustariz, C.; Vert, M.; Davies, M.C. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J. Control. Release, 1999, 59(3), 261-278.
    • (1999) J. Control. Release , vol.59 , Issue.3 , pp. 261-278
    • Scholes, P.D.1    Coombes, A.G.A.2    Illum, L.3    Davis, S.S.4    Watts, J.F.5    Ustariz, C.6    Vert, M.7    Davies, M.C.8
  • 25
    • 0026468796 scopus 로고
    • Measurements of temperatures, ice evaporation rates and residual moisture contents in freeze-drying
    • [25] Willemer, H. Measurements of temperatures, ice evaporation rates and residual moisture contents in freeze-drying. Dev. Biol. Stand., 1992, 74(123-134.
    • (1992) Dev. Biol. Stand , vol.74 , pp. 123-134
    • Willemer, H.1
  • 26
    • 0001904754 scopus 로고
    • Freeze-drying of proteins
    • Part I: process design
    • Pikal, M.J. Freeze-drying of proteins. Part I: process design. Biopharm, 1990, 3(8), 18-27.
    • (1990) Biopharm , vol.3 , Issue.8 , pp. 18-27
    • Pikal, M.J.1
  • 27
    • 34547800192 scopus 로고    scopus 로고
    • Freeze-drying of nanoparticles: Formulation, process and storage considerations
    • Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev., 2006, 58(15), 1688-1713.
    • (2006) Adv. Drug Deliv. Rev , vol.58 , Issue.15 , pp. 1688-1713
    • Abdelwahed, W.1    Degobert, G.2    Stainmesse, S.3    Fessi, H.4
  • 28
    • 0027471239 scopus 로고
    • The effect of carbohydrate additives in the freezedrying of alkaline phosphatase
    • Ford, A.W.; Dawson, P.J. The effect of carbohydrate additives in the freezedrying of alkaline phosphatase. J. Pharm. Pharmacol., 1993, 45(2), 86-93.
    • (1993) J. Pharm. Pharmacol , vol.45 , Issue.2 , pp. 86-93
    • Ford, A.W.1    Dawson, P.J.2
  • 29
    • 0030770631 scopus 로고    scopus 로고
    • Rational design of stable lyophilized protein formulations: Some practical advice
    • Carpenter, J.F.; Pikal, M.J.; Chang, B.S.; Randolph, T.W. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res., 1997, 14(8), 969-975.
    • (1997) Pharm. Res , vol.14 , Issue.8 , pp. 969-975
    • Carpenter, J.F.1    Pikal, M.J.2    Chang, B.S.3    Randolph, T.W.4
  • 30
    • 0002469071 scopus 로고
    • Preserving dry biomaterials: The water replacement hypothesis
    • Crowe, J.H.; Crowe, L.M.; Carpenter, J.F. Preserving dry biomaterials: the water replacement hypothesis. Biopharm, 1993, 6(3), 28-37.
    • (1993) Biopharm , vol.6 , Issue.3 , pp. 28-37
    • Crowe, J.H.1    Crowe, L.M.2    Carpenter, J.F.3
  • 31
    • 0032851413 scopus 로고    scopus 로고
    • Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method
    • Murakami, H.; Kobayashi, M.; Takeuchi, H.; Kawashima, Y. Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm., 1999, 187(2), 143-152.
    • (1999) Int. J. Pharm , vol.187 , Issue.2 , pp. 143-152
    • Murakami, H.1    Kobayashi, M.2    Takeuchi, H.3    Kawashima, Y.4
  • 32
    • 0033019164 scopus 로고    scopus 로고
    • Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: Influence on physical stability and in vitro cell uptake
    • De Jaeghere, F.; Allemann, E.; Leroux, J.C.; Stevels, W.; Feijen, J.; Doelker, E.; Gurny, R. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm. Res., 1999, 16(6), 859-866.
    • (1999) Pharm. Res , vol.16 , Issue.6 , pp. 859-866
    • de Jaeghere, F.1    Allemann, E.2    Leroux, J.C.3    Stevels, W.4    Feijen, J.5    Doelker, E.6    Gurny, R.7
  • 34
    • 0021347286 scopus 로고
    • Rheological properties of poloxamer vehicles
    • Miller, S.C.; Drabik, B.R. Rheological properties of poloxamer vehicles. Int. J. Pharm., 1984, 18(3), 269-276.
    • (1984) Int. J. Pharm , vol.18 , Issue.3 , pp. 269-276
    • Miller, S.C.1    Drabik, B.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.